Articles

Choice PharmD interpretation services help bridge the gap between molecular diagnostics and clinical decision-making. Once PCR technology identifies pathogens and resistance genes, a clinical pharmacist reviews the data, applies evidence-based reasoning, and produces concise therapeutic options tailored to the patient. The final Choice PharmD report integrates directly into the laboratory information system so clinicians see detection results and recommended therapy side-by-s

Molecular diagnostics today can identify bacteria and resistance genes with remarkable precision. But precise data alone doesn’t always equal clear treatment decisions. Too often, clinicians receive lab reports that show what is present—but not what to do next.That’s exactly where Choice PharmD Reports make the difference. We translate complex genetic results into clear, evidence-based therapeutic guidance that clinicians can trust. Each report bridges the gap between lab sci

Interpretive reports (e.g. PharmD reports) of molecular diagnostic tests deliver critical therapeutic guidance by supplementing the...